A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome

BACKGROUND: Type 1 diabetes mellitus (T1DM) is a rare, but serious immune-related adverse event (irAE) of immune checkpoint inhibitors (ICIs). Our goal was to characterize treatment outcomes associated with ICI-induced T1DM through analysis of clinical, immunological and proteomic data. METHODS: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsiglio, John, McPherson, Jordan P., Kovacsovics-Bankowski, Magdalena, Jeter, Joanne, Vaklavas, Christos, Swami, Umang, Grossmann, Douglas, Erickson-Wayman, Alyssa, Soares, Heloisa P., Kerrigan, Katie, Gibson, Berit, Doherty, Jennifer Anne, Hyngstrom, John, Hardikar, Sheetal, Hu-Lieskovan, Siwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475559/
https://www.ncbi.nlm.nih.gov/pubmed/37671166
http://dx.doi.org/10.3389/fimmu.2023.1229823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475559/
https://www.ncbi.nlm.nih.gov/pubmed/37671166
http://dx.doi.org/10.3389/fimmu.2023.1229823

Ejemplares similares